Items where authors include "Smolen, J.S."

Article

Yazji, S.M., Helliwell, P.S. orcid.org/0000-0002-4155-9105, Balanescu, A. et al. (9 more authors) (2025) Association between patient perception of disease status and different components of the Minimal Disease Activity (MDA) criteria in psoriatic arthritis. The Journal of Rheumatology. ISSN 0315-162X

Zabotti, A. orcid.org/0000-0002-0573-464X, Fagni, F. orcid.org/0000-0002-6122-0774, Gossec, L. orcid.org/0000-0002-4528-310X et al. (15 more authors) (2024) Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD Open, 10 (2). e004314. ISSN 2056-5933

Kerschbaumer, A., Smolen, J.S., Nash, P. et al. (12 more authors) (2020) Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : a systematic literature research. RMD Open, 6 (3). e001374.

Kerschbaumer, A., Sepriano, A., Smolen, J.S. et al. (9 more authors) (2020) Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Annals of the Rheumatic Diseases, 79 (6). pp. 744-759. ISSN 0003-4967

Proceedings Paper

Zabotti, A., De Marco, G. orcid.org/0000-0003-2406-161X, Gossec, L. et al. (26 more authors) (2023) OP0062 EULAR points to consider for the definition of clinical and imaging features suspicious for progression to psoriatic arthritis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 42-43.